Drug Companies Spend Record On Lobbying

Law360, New York (April 3, 2007, 12:00 AM EDT) -- Health companies spent $182 million lobbying Capitol Hill between January 2005 and June 2006, setting a record as they weighed in on issues from drug prices to drug safety, a public interest group has found.

Drug makers shelled out the bulk of that sum, spending $155 million and hiring 1,100 lobbyists to fight for such issues as keeping cheaper Canadian pharmaceuticals out of the country and protecting lucrative drug patents, a study by the Center for Public Integrity said.

Pharmaceutical companies “have been facing an increasingly...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.